Evidence map›Paper›PMID 36527015›Full record

ArticleBMC public health2022

Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain.

Ángel Gil-de-Miguel, Federico Martinón-Torres, Javier Díez-Domingo, Raúl Ortiz de Lejarazu Leonardo, Tomàs Pumarola, Mafalda Carmo, Georgina Drago, Juan Luis López-Belmonte, Hélène Bricout, Caroline de Courville and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Ángel Gil-de-MiguelPublic Health and Medical Specialties Department, Health Sciences Faculty, Juan Carlos University, Madrid, Spain. angel.gil@urjc.es.
Federico Martinón-TorresGenetics, Vaccines and Paediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain.ORCID 0000-0002-9023-581X
Javier Díez-DomingoVaccine Research Department, FISABIO, Valencia, Spain.
Raúl Ortiz de Lejarazu LeonardoNational Influenza Centre, Hospital Clínico Universitario, Universidad de Valladolid, Valladolid, Spain.
Tomàs PumarolaVirology Section, Department of Microbiology, Barcelona Centre for International Health Research (CRESIB, Hospital Clínic - Universitat de Barcelona), Barcelona, Spain.
Mafalda CarmoIQVIA, Barcelona, Spain.
Georgina DragoSanofi, Barcelona, Spain.
Juan Luis López-BelmonteSanofi, Barcelona, Spain.
Hélène BricoutSanofi, Lyon, France.
Caroline de CourvilleSanofi, Lyon, France.
Esther Redondo MargüelloInternational Health Centre Madrid Health, City Council of Madrid, Madrid, Spain.
Sanofi (France) · FRSanofi (Spain) · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital Clínic de Barcelona · ESInstituto Químico Biológico · ESMadrid Health Service · ESUniversidad de Valladolid · ESUniversidade de Santiago de Compostela · ESUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfluenza is an acutely debilitating respiratory infection, contributing significantly to outpatient visits and hospitalizations. Spain lacks comprehensive and updated data on the burden of influenza, particularly in the outpatient setting. Our study aimed to fill this gap by estimating the clinical and economic burden of physician-diagnosed influenza cases in adults from four Spanish regions, stratified by age groups and presence of comorbidities.

methodsA retrospective cost-of-illness study was conducted using data from an electronic medical records database from the National Healthcare Service (NHS) of four Spanish regions for individuals aged ≥ 18 years diagnosed for influenza during the 2017/2018 epidemic season. Health resource utilization and related cost data were collected, including primary care visits, referrals to other specialists, visits to the emergency department, hospitalizations, and prescribed medicines.

resultsThe study reported a total of 28,381 patients aged ≥ 18 years diagnosed with influenza, corresponding to 1,804 cases per 100,000 population. Most patients were aged < 65 years: 60.5% (n = 17,166) aged 18-49 and 26.3% (n = 7,451) 50-64 years. A total of 39.2% (n = 11,132) of patients presented a comorbidity. Cardiovascular diseases were the most common comorbidity reported along with influenza. The mean healthcare cost per case was estimated at €235.1 in population aged 18-49 years, increasing by 1.7 and 4.9 times in those aged 50-64 (€402.0) and ≥ 65 (€1,149.0), respectively. The mean healthcare cost per case was 3.2 times higher in patients with comorbidities. The total healthcare cost of medically attended influenza cases was mainly driven by primary care (45.1%) and hospitalization (42.0%). Patients aged 18-64 years old accounted for 61.9% of the costs of medically attended influenza. Irrespective of age, patients with comorbidities accounted for 67.1% of costs.

conclusionsSeason 2017/2018 was associated with a considerable burden of influenza in Spain, which increased with age and presence of comorbidities. Individuals with comorbidities accounted for most of the costs of influenza. Results suggest that population aged 18-64 years old is generating the highest share of costs to the NHS when all healthcare costs are considered. Preventive strategies targeting subjects with comorbidities, regardless of age, should be warranted.

Indexed as

Influenza, HumanPhysiciansAdolescentAdultCost of IllnessFinancial StressHealth Care CostsHospitalizationHumansMiddle AgedRetrospective StudiesSeasonsSpainYoung AdultBurdenCost analysisEpidemiologyHealth resourcesHospitalizationInfluenzaMedical emergency serviceOutpatientsPrimary health careSpain

Identifiers

PMID36527015
PMCPMC9758854
OpenAlexW4312065117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.